| 2025 |
Heatlie, J. K., Lazniewska, J., Moore, C. R., Johnson, I. R. D., Nturubika, B. D., Williams, R., . . . Brooks, D. A. (2025). Extracellular Vesicles and Tunnelling Nanotubes as Mediators of Prostate Cancer Intercellular Communication. Biomolecules, 15(1), 23.
DOI Scopus5 WoS4 Europe PMC3 |
| 2025 |
Li, K. L., Hickey, S. M., Albrecht, H., Logan, J. M., Lazniewska, J., Moore, C. R., . . . Brooks, D. A. (2025). Targeting prostate cancer cells using anti-sortilin and anti-syndecan-1 antibody drug conjugates. International Journal Of Molecular Sciences, 26(22, article no. 11145), 25 pages.
DOI |
| 2024 |
Rajapaksha, W., Khetan, R., Johnson, I. R. D., Blencowe, A., Garg, S., Albrecht, H., & Gillam, T. A. (2024). Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment. Frontiers in Drug Delivery, 4(1339936), 19 pages.
DOI Scopus10 WoS7 Europe PMC2 |
| 2024 |
Tang, J., Lam, G. T., Brooks, R. D., Miles, M., Useckaite, Z., Johnson, I. R., . . . Logan, J. M. (2024). Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system. Cancer Letters, 585(216639), 216639-1-216639-9.
DOI Scopus9 WoS11 Europe PMC11 |
| 2024 |
Bader, C. A., Simpson, P. V., Dallerba, E., Stagni, S., Johnson, I. R. D., Hickey, S. M., . . . Plush, S. E. (2024). Synthesis and cellular uptake of neutral rhenium(i) morpholine complexes. Dalton Transactions, 53(7), 3407-3413.
DOI Scopus2 WoS2 Europe PMC1 |
| 2024 |
Logan, J. M., Martini, C., Sorvina, A., Johnson, I. R. D., Brooks, R. D., Caruso, M. C., . . . Ung, B. S. -Y. (2024). Reinterpretation of prostate cancer pathology by Appl1, Sortilin and Syndecan-1 biomarkers. Scientific data, 11(1), 852-1-852-10.
DOI Scopus3 WoS2 Europe PMC1 |
| 2024 |
Nturubika, B. D., Guardia, C. M., Gershlick, D. C., Logan, J. M., Martini, C., Heatlie, J. K., . . . Johnson, I. R. D. (2024). Altered expression of vesicular trafficking machinery in prostate cancer affects lysosomal dynamics and provides insight into the underlying biology and disease progression. British Journal of Cancer, 131(8), 1263-1278.
DOI Scopus2 WoS2 Europe PMC2 |
| 2024 |
Nturubika, B. D. D., Logan, J., Johnson, I. R. D., Moore, C., Li, K. L., Tang, J., . . . Brooks, D. A. (2024). Components of the endosome-lysosome vesicular machinery as drivers of the metastatic cascade in prostate cancer. Cancers, 17(1), 1, article no. 43-31.
DOI Scopus2 WoS2 Europe PMC1 |
| 2023 |
Martini, C., Logan, J. M., Sorvina, A., Gordon, C., Beck, A. R., S-Y Ung, B., . . . Brooks, D. A. (2023). Aberrant protein expression of Appl1, Sortilin and Syndecan-1 during the biological progression of prostate cancer. Pathology, 55(1), 40-51.
DOI Scopus19 WoS18 Europe PMC18 |
| 2023 |
Hickey, S. M., Johnson, I. R. D., Dallerba, E., Hackett, M. J., Massi, M., Lazniewska, J., . . . Ashton, T. D. (2023). A fluorescent and solvatochromic 1,8-naphthalimide probe for detection of lipid droplet trafficking and biogenesis. Dyes and Pigments, 217(111382), 111382-1-111382-6.
DOI Scopus11 WoS11 |
| 2023 |
Logan, J. M., Hopkins, A. M., Martini, C., Sorvina, A., Tewari, P., Prabhakaran, S., . . . Brooks, D. A. (2023). Prediction of Prostate Cancer Biochemical and Clinical Recurrence Is Improved by IHC-Assisted Grading Using Appl1, Sortilin and Syndecan-1.. Cancers, 15(12), 1-12.
DOI Scopus10 WoS9 Europe PMC7 |
| 2023 |
Sorvina, A., Martini, C., Prabhakaran, S., Logan, J. M., Ung, B. S. Y., Moore, C., . . . Brooks, D. A. (2023). Appl1, Sortilin and Syndecan-1 immunohistochemistry on intraductal carcinoma of the prostate provides evidence of retrograde spread. Pathology, 55(6), 792-799.
DOI Scopus10 WoS10 Europe PMC9 |
| 2023 |
Lam, G. T., Sorvina, A., Martini, C., Prabhakaran, S., Ung, B. S. Y., Lazniewska, J., . . . Logan, J. M. (2023). Altered endosomal-lysosomal biogenesis in melanoma. Neoplasia, 43(100924), 1-10.
DOI Scopus5 WoS5 Europe PMC3 |
| 2023 |
Lazniewska, J., Li, K. L., Johnson, I. R. D., Sorvina, A., Logan, J. M., Martini, C., . . . Brooks, D. A. (2023). Dynamic interplay between sortilin and syndecan-1 contributes to prostate cancer progression. Scientific reports, 13(1, article no. 13489), 1-18.
DOI Scopus13 WoS12 Europe PMC10 |
| 2023 |
Lam, G. T., Martini, C., Brooks, T., Prabhakaran, S., Hopkins, A. M., Ung, B. S. -Y., . . . Logan, J. M. (2023). Insights into Melanoma Clinical Practice: A Perspective for Future Research. Cancers, 15(18), 4631-1-4631-9.
DOI Scopus3 WoS3 Europe PMC3 |
| 2023 |
Martini, C., Logan, J. M., Sorvina, A., Prabhakaran, S., Ung, B. S. Y., Johnson, I. R. D., . . . Brooks, D. A. (2023). Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer. Virchows Archiv, 485(4), 723-728.
DOI Scopus3 WoS3 Europe PMC2 |
| 2023 |
Martini, C., Logan, J. M., Sorvina, A., Prabhakaran, S., Ung, B. S. Y., Johnson, I. R. D., . . . Brooks, D. A. (2023). Publisher Correction to: Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer (Virchows Archiv, (2023), 10.1007/s00428-023-03643-1). Virchows Archiv, 487(1), 245.
DOI |
| 2023 |
Cortés Sánchez, J. L., Melnik, D., Sandt, V., Kahlert, S., Marchal, S., Johnson, I. R. D., . . . Krüger, M. (2023). Fluid and bubble flow detach adherent cancer cells to form spheroids on a random positioning machine. Cells, 12(22, article no. 2665), 1-27.
DOI |
| 2022 |
Lam, G. T., Prabhakaran, S., Sorvina, A., Martini, C., Ung, B. S. Y., Karageorgos, L., . . . Logan, J. M. (2022). Pitfalls in cutaneous melanoma diagnosis and the need for new reliable markers. Molecular Diagnosis and Therapy, 27(1), 49-60.
DOI Scopus15 WoS14 Europe PMC12 |
| 2022 |
Hickey, S. M., Ung, B., Bader, C., Brooks, R., Lazniewska, J., Johnson, I. R. D., . . . Brooks, D. A. (2022). Fluorescence microscopy-an outline of hardware, biological handling, and fluorophore considerations. Cells, 11(35), 1-32.
DOI Scopus89 WoS70 Europe PMC48 |
| 2022 |
Johnson, I. R. D., Rudebeck, E. E., Sweetman, M. J., Sorvina, A., Ashton, T. D., Pfeffer, F. M., . . . Hickey, S. M. (2022). A 3,4-dimethoxy-1,8-naphthalimide for lipid droplet imaging in live and fixed cells. Sensors and Actuators B: Chemical, 365(131921), 131921-1-131921-7.
DOI Scopus12 WoS9 |
| 2020 |
Johnson, I. R. D., Nguyen, C. T., Wise, P., & Grimm, D. (2020). Implications of altered endosome and lysosome biology in space environments. International Journal of Molecular Sciences, 21(8205), 1-19.
DOI |
| 2019 |
Johnson, I. R. D., & Logan, J. M. (2019). 'Seeing is Believing': enhancing student engagement with dynamic protein-model visualization. Biochemistry and molecular biology education, 47(3), 247-248.
DOI |
| 2019 |
Johnson, I. R. D., Sorvina, A., Logan, J. M., Moore, C. R., Heatlie, J. K., Parkinson-Lawrence, E. J., . . . Brooks, D. A. (2019). A paradigm in immunochemistry, revealed by monoclonal antibodies to spatially distinct epitopes on Syntenin-1. International Journal of Molecular Sciences, 20(23), 6035-1-6035-16.
DOI Scopus7 WoS7 Europe PMC5 |
| 2018 |
Armstrong, H., Gillis, J., Johnson, I., Nassar, Z., Moldovan, M., Levrier, C., . . . Butler, L. (2018). Dysregulated fibronectin trafficking by Hsp90 inhibition restricts prostate cancer cell invasion. Scientific reports, 8(1), 2090-1-2090-14.
DOI Scopus32 WoS32 Europe PMC30 |
| 2018 |
Sorvina, A., Bader, C. A., Darby, J. R. T., Lock, M. C., Soo, J. Y., Johnson, I. R. D., . . . Brooks, D. A. (2018). Mitochondrial imaging in live or fixed tissues using a luminescent iridium complex. Scientific Reports, 8(1, article no. 8191), 8191-1-8191-8.
DOI Scopus33 WoS29 Europe PMC22 |
| 2018 |
Harrison, I. P., Vinh, A., Johnson, I. R. D., Luong, R., Drummond, G. R., Sobey, C. G., . . . Selemidis, S. (2018). NOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development. Oncotarget, 9(83), 35378-35393.
DOI Scopus27 Europe PMC24 |
| 2018 |
Sorvina, A., Bader, C. A., Caporale, C., Carter, E. A., Johnson, I. R. D., Parkinson Lawrence, E. J., . . . Plush, S. E. (2018). Lipid profiles of prostate cancer cells. Oncotarget, 9(85), 35541-35552.
DOI Scopus39 Europe PMC25 |
| 2016 |
Zhang, W., Garg, S., Eldi, P., Zhou, F., Johnson, I., Brooks, D., . . . Albrecht, H. (2016). Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide. International Journal of Pharmaceutics, 513(1-2), 270-279.
DOI Scopus27 WoS25 Europe PMC17 |
| 2015 |
Johnson, I., Parkinson-Lawrence, E., Keegan, H., Spillane, C., Barry-O'Crowley, J., Watson, W., . . . Brooks, D. (2015). Endosomal gene expression: a new indicator for prostate cancer patient prognosis?. Oncotarget, 6(35), 37919-37929.
DOI Scopus40 WoS37 Europe PMC38 |
| 2015 |
Bader, C., Shandala, T., Ng, Y., Johnson, I., & Brooks, D. (2015). Atg9 is required for intraluminal vesicles in amphisomes and autolysosomes. Biology Open, 4(11), 1345-1355.
DOI Scopus45 WoS43 Europe PMC41 |
| 2014 |
Johnson, I., Parkinson-Lawrence, E., Shandala, T., Weigert, R., Butler, L., & Brooks, D. (2014). Altered endosome biogenesis in prostate cancer has biomarker potential. Molecular Cancer Research, 12(12), 1851-1862.
DOI Scopus44 WoS43 Europe PMC38 |
| 2014 |
Johnson, I., Parkinson-Lawrence, E., Butler, L., & Brooks, D. (2014). Prostate cell lines as models for biomarker discovery: performance of current markers and the search for new biomarkers. Prostate, 74(5), 547-560.
DOI Scopus22 WoS20 Europe PMC17 |
